ContextVision – Page 2 – ContextVision

Strong second quarter with solid margin growth

ContextVision, Financial reports, Home, Investor News 2023-08-24

“Our impressive performance was fuelled by the excellent licensing sales in our core business and boosted by favourable foreign exchange rates. We anticipate our margins to remain stable, consistently reaching a high level of 40 in the foreseeable future”, says Gerald Pötzsch, CEO of ContextVision.

Major Shareholder Notification in ContextVision

ContextVision, Home, Investor News 2023-07-24

Major Shareholder Notification in ContextVision

ContextVision AB: Ex dividend SEK 0,15 today

ContextVision, Home, Investor News 2023-05-08

The shares in ContextVision AB will be traded ex dividend SEK 0,15 as from today, 8 May 2023. newsweb.oslobors.no

ContextVision AB – Key information relating payment of cash dividend * Correction

ContextVision, Home, Investor News, News 2023-05-04

Key information relating payment of cash dividend * Correction

ContextVision distributes cash dividend of SEK 0.30 per share

ContextVision, Home, Investor News, News 2023-05-03

On May 3rd 2023, ContextVision held its ordinary Shareholders’ Annual General Meeting in Stockholm. The company’s robust growth in 2022 and the successful spin off of Inify Laboratories AB has resulted in a strong balance sheet. In the light of this background and in line with the board’s recommendation, the Meeting resolved on a dividend […]

Continued strong growth

ContextVision, Financial reports, Home, Investor News, News 2023-04-27

ContextVision today proudly presents their Q1 Report for 2023.

ContextVision – Invitation to Annual General Meeting 2023

ContextVision, Digital Pathology, Home, Investor News, News 2023-03-30

STOCKHOLM – March 30, 2023 – ContextVision hereby invites shareholders to the Annual General Meeting on May 3, 2023. Please find attached the invitation including agenda and details on how to register and vote. Please contact: for any questions regarding the AGM. For inquiries, please contact CFO Markus Hökerberg E-mail:

Annual report 2022 – record sales with full focus on growing the core business

Annual reports, ContextVision, Home, Investor News, News 2023-03-30

STOCKHOLM – March 30th, 2023 – ContextVision, a medical technology software company specializing in image processing and image analysis, today presents their Annual Report for 2022. The Annual Report gives additional information about the record year, where net sales increased by 20% compared to 2021, and EBITDA ended at 49 MSEK or 42%. 2022 was […]

Strong Q4 and a record full year 2022

ContextVision, Financial reports, Home, Investor News, News 2023-02-16

STOCKHOLM – Feb 16, 2023 – ContextVision, a medical technology software company specializing in image processing and image analysis, today reports its fourth quarter results. Net sales record The company delivers another record quarter with a net sales of SEK 32.6 M, an increase of 19%. For the full year, net sales increased 20% to […]

ContextVision Showcases Latest Image Enhancement, Accelerates Growth Globally with Focus on Core Offerings

ContextVision, Home, News 2022-11-22

ContextVision Showcases Latest Image Enhancement, Accelerates Growth Globally with Focus on Core Offerings. ContextVision, a medical technology software company specializing in image quality, will be highlighting its comprehensive suite of image enhancement solutions aimed at improving patient diagnoses at RSNA 2022.